Hikma Pharmaceutical | HIK - Operating Profit

Stock Price
1,652.00
Daily Change
-1.00 -0.06%
Monthly
5.36%
Yearly
-23.31%
Q1 Forecast
1,600.34

Hikma Pharmaceutical reported $187M in Operating Profit for its fiscal semester ending in June of 2025.





Operating Profit Change Date
Almirall EUR 30.23M 12.8M Dec/2025
argenx SE USD 349.97M 146.13M Sep/2025
AstraZeneca USD 2.97B 4.48B Dec/2025
Autolus Therapeutics Ltd USD -82.61M 17.37M Jun/2025
Bayer EUR -543M 556M Sep/2025
Fresenius EUR 574M 14M Sep/2025
Galapagos EUR -41.67M 15.36M Sep/2025
Genmab DKK 360M 172M Jun/2025
GlaxoSmithKline GBP 1.44B 1.35B Dec/2025
GRIFOLS EUR 352.11M 2.57M Sep/2025
Hikma Pharmaceutical USD 187M 95M Jun/2025
Lonza CHF 430M 104M Dec/2024
Merck EUR 1.21B 180M Sep/2025
Orion EUR 328.2M 207.2M Dec/2025
Recordati EUR 278.23M 112.58M Dec/2025
Roche Holding CHF 9.56B 3.8B Dec/2025
Sanofi EUR 1.7B 2.17B Dec/2025
UCB EUR 1B 678M Dec/2024